{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:43:56Z","timestamp":1785336236289,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04522-z","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T07:29:31Z","timestamp":1755674971000},"page":"2307-2319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HRASLS2 promotes the growth and glycolysis of pancreatic cancer by enhancing the stability of ASPH"],"prefix":"10.1007","volume":"399","author":[{"given":"Ying","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"4","key":"4522_CR1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hep.27275","volume":"60","author":"A Aihara","year":"2014","unstructured":"Aihara A, Huang CK, Olsen MJ et al (2014) A cell-surface \u03b2-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Hepatology 60(4):1302\u20131313. https:\/\/doi.org\/10.1002\/hep.27275","journal-title":"Hepatology"},{"issue":"9","key":"4522_CR2","first-page":"4141","volume":"11","author":"X Bai","year":"2021","unstructured":"Bai X, Zhou Y, Lin Q et al (2021) Bio-nanoparticle based therapeutic vaccine induces immunogenic response against triple negative breast cancer. Am J Cancer Res 11(9):4141\u20134174","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4522_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC (2016) Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res 18(1):84. https:\/\/doi.org\/10.1186\/s13058-016-0740-2","journal-title":"Breast Cancer Res"},{"issue":"12","key":"4522_CR4","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41416-022-01752-3","volume":"126","author":"CJ Cabasag","year":"2022","unstructured":"Cabasag CJ, Arnold M, Rutherford M et al (2022) Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. Br J Cancer 126(12):1774\u20131782. https:\/\/doi.org\/10.1038\/s41416-022-01752-3","journal-title":"Br J Cancer"},{"issue":"3","key":"4522_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/br.2023.1604","volume":"18","author":"YN Chen","year":"2023","unstructured":"Chen YN, Shih CY, Guo SL et al (2023) Potential prognostic and predictive value of UBE2N, IMPDH1, DYNC1LI1 and HRASLS2 in colorectal cancer stool specimens. Biomed Rep 18(3):22. https:\/\/doi.org\/10.3892\/br.2023.1604","journal-title":"Biomed Rep"},{"issue":"46","key":"4522_CR6","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","volume":"27","author":"MR Goulart","year":"2021","unstructured":"Goulart MR, Stasinos K, Fincham REA, Delvecchio FR, Kocher HM (2021) T cells in pancreatic cancer stroma. World J Gastroenterol 27(46):7956\u20137968. https:\/\/doi.org\/10.3748\/wjg.v27.i46.7956","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4522_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.17305\/bjbms.2018.3539","volume":"18","author":"G Hou","year":"2018","unstructured":"Hou G, Xu B, Bi Y et al (2018) Recent advances in research on aspartate \u03b2-hydroxylase (ASPH) in pancreatic cancer: a brief update. Bosn J Basic Med Sci 18(4):297\u2013304. https:\/\/doi.org\/10.17305\/bjbms.2018.3539","journal-title":"Bosn J Basic Med Sci"},{"issue":"5","key":"4522_CR8","first-page":"1261","volume":"60","author":"N Ince","year":"2000","unstructured":"Ince N, de la Monte SM, Wands JR (2000) Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res 60(5):1261\u20131266","journal-title":"Cancer Res"},{"issue":"1","key":"4522_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13046-020-01669-w","volume":"39","author":"M Kanwal","year":"2020","unstructured":"Kanwal M, Smahel M, Olsen M, Smahelova J, Tachezy R (2020) Aspartate beta-hydroxylase as a target for cancer therapy. J Exp Clin Cancer Res 39(1):163. https:\/\/doi.org\/10.1186\/s13046-020-01669-w","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4522_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12935-022-02836-z","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Yin J, Li W, Wang H, Ni B (2023) Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Cancer Cell Int 23(1):7. https:\/\/doi.org\/10.1186\/s12935-022-02836-z","journal-title":"Cancer Cell Int"},{"issue":"9","key":"4522_CR11","doi-asserted-by":"publisher","first-page":"e10416","DOI":"10.1016\/j.heliyon.2022.e10416","volume":"8","author":"TH Li","year":"2022","unstructured":"Li TH, Wang YY, Zhao BB, Qin C, Li ZR, Wang WB (2022) Phospholipase A\/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. Heliyon 8(9):e10416. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10416","journal-title":"Heliyon"},{"key":"4522_CR12","doi-asserted-by":"publisher","first-page":"1170223","DOI":"10.3389\/fimmu.2023.1170223","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Du Y, Jiang W et al (2023) Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer. Front Immunol 14:1170223. https:\/\/doi.org\/10.3389\/fimmu.2023.1170223","journal-title":"Front Immunol"},{"issue":"2","key":"4522_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1053\/j.gastro.2021.04.041","volume":"161","author":"Y Lu","year":"2021","unstructured":"Lu Y, Li Y, Liu Q et al (2021) MondoA-thioredoxin-interacting protein axis maintains regulatory T-cell identity and function in colorectal cancer microenvironment. Gastroenterology. 161(2):575\u2013591.e516. https:\/\/doi.org\/10.1053\/j.gastro.2021.04.041","journal-title":"Gastroenterology."},{"key":"4522_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12929-015-0210-7","volume":"22","author":"EB Mardian","year":"2015","unstructured":"Mardian EB, Bradley RM, Duncan RE (2015) The HRASLS (PLA\/AT) subfamily of enzymes. J Biomed Sci 22:99. https:\/\/doi.org\/10.1186\/s12929-015-0210-7","journal-title":"J Biomed Sci"},{"key":"4522_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.canlet.2019.02.006","volume":"449","author":"K Nagaoka","year":"2019","unstructured":"Nagaoka K, Bai X, Ogawa K et al (2019) Anti-tumor activity of antibody drug conjugate targeting aspartate-\u03b2-hydroxylase in pancreatic ductal adenocarcinoma. Cancer Lett 449:87\u201398. https:\/\/doi.org\/10.1016\/j.canlet.2019.02.006","journal-title":"Cancer Lett"},{"issue":"1","key":"4522_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13148-019-0728-8","volume":"11","author":"F Natale","year":"2019","unstructured":"Natale F, Vivo M, Falco G, Angrisano T (2019) Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis. Clin Epigenetics 11(1):132. https:\/\/doi.org\/10.1186\/s13148-019-0728-8","journal-title":"Clin Epigenetics"},{"issue":"6","key":"4522_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH (2018) Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol 15(6):333\u2013348. https:\/\/doi.org\/10.1038\/s41575-018-0005-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4522_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13045-019-0837-z","volume":"12","author":"K Ogawa","year":"2019","unstructured":"Ogawa K, Lin Q, Li L et al (2019) Aspartate \u03b2-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. J Hematol Oncol 12(1):144. https:\/\/doi.org\/10.1186\/s13045-019-0837-z","journal-title":"J Hematol Oncol"},{"key":"4522_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2020.02.039","volume":"481","author":"K Ogawa","year":"2020","unstructured":"Ogawa K, Lin Q, Li L et al (2020) Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis. Cancer Lett 481:63\u201375. https:\/\/doi.org\/10.1016\/j.canlet.2020.02.039","journal-title":"Cancer Lett"},{"key":"4522_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL (2023) Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu Rev Pathol 18:123\u2013148. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031621-024600","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"4522_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00726-007-0612-2","volume":"35","author":"RY Shyu","year":"2008","unstructured":"Shyu RY, Hsieh YC, Tsai FM, Wu CC, Jiang SY (2008) Cloning and functional characterization of the HRASLS2 gene. Amino Acids 35(1):129\u2013137. https:\/\/doi.org\/10.1007\/s00726-007-0612-2","journal-title":"Amino Acids"},{"issue":"1","key":"4522_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"4522_CR23","doi-asserted-by":"publisher","first-page":"1237711","DOI":"10.3389\/fimmu.2023.1237711","volume":"14","author":"P Storz","year":"2023","unstructured":"Storz P (2023) Roles of differently polarized macrophages in the initiation and progression of pancreatic cancer. Front Immunol 14:1237711. https:\/\/doi.org\/10.3389\/fimmu.2023.1237711","journal-title":"Front Immunol"},{"issue":"18","key":"4522_CR24","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/1873-3468.12787","volume":"591","author":"T Uyama","year":"2017","unstructured":"Uyama T, Tsuboi K, Ueda N (2017) An involvement of phospholipase A\/acyltransferase family proteins in peroxisome regulation and plasmalogen metabolism. FEBS Lett 591(18):2745\u20132760. https:\/\/doi.org\/10.1002\/1873-3468.12787","journal-title":"FEBS Lett"},{"key":"4522_CR25","doi-asserted-by":"publisher","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM (2022) Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 163(2):386\u2013402.e381. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056","DOI":"10.1053\/j.gastro.2022.03.056"},{"issue":"12","key":"4522_CR26","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1136\/gutjnl-2023-330155","volume":"72","author":"Y Wu","year":"2023","unstructured":"Wu Y, Seufert I, Al-Shaheri FN et al (2023) DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma. Gut 72(12):2344\u20132353. https:\/\/doi.org\/10.1136\/gutjnl-2023-330155","journal-title":"Gut"},{"issue":"21","key":"4522_CR27","doi-asserted-by":"publisher","first-page":"12642","DOI":"10.1111\/jcmm.15832","volume":"24","author":"W Xia","year":"2020","unstructured":"Xia W, Bai H, Deng Y, Yang Y (2020) PLA2G16 is a mutant p53\/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer. J Cell Mol Med 24(21):12642\u201312655. https:\/\/doi.org\/10.1111\/jcmm.15832","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4522_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2159-8290.CD-19-0958","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lazarus J, Steele NG et al (2020) Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. Cancer Discov 10(3):422\u2013439. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0958","journal-title":"Cancer Discov"},{"issue":"1","key":"4522_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-021-02216-x","volume":"41","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Lin J, Yan Y et al (2022) INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. J Exp Clin Cancer Res 41(1):13. https:\/\/doi.org\/10.1186\/s13046-021-02216-x","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04522-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:46:53Z","timestamp":1770882413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04522-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4522"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04522-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Ethics Committee of Affiliated Hospital of North Sichuan Medical College (approval number: 2025029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}